4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-21-045948
Chief Medical Officer sold 58,261 shares at an average $54.04 ($3,148,172)
- Chief Medical Officer acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Detke Michael J. Chief Medical Officer | 2021-07-06 | Option exercise | +12,600 | $2.23 | $28,098 | 40,861 | D: show line 1 in the form |
| Detke Michael J. Chief Medical Officer | 2021-07-06 | Sale | −32,313 | $53.43 | $1,726,484 | 8,548 | D: show line 2 in the form |
| Detke Michael J. Chief Medical Officer | 2021-07-06 | Sale | −8,260 | $53.91 | $445,297 | 288 | D: show line 3 in the form |
| Detke Michael J. Chief Medical Officer | 2021-07-06 | Sale | −288 | $55.01 | $15,843 | 0 | D: show line 4 in the form |
| Detke Michael J. Chief Medical Officer | 2021-07-07 | Option exercise | +17,400 | $2.23 | $38,802 | 17,400 | D: show line 5 in the form |
| Detke Michael J. Chief Medical Officer | 2021-07-07 | Sale | −3,934 | $53.24 | $209,446 | 13,466 | D: show line 6 in the form |
| Detke Michael J. Chief Medical Officer | 2021-07-07 | Sale | −1,648 | $54.37 | $89,602 | 11,818 | D: show line 7 in the form |
| Detke Michael J. Chief Medical Officer | 2021-07-07 | Sale | −4,353 | $55.38 | $241,069 | 7,465 | D: show line 8 in the form |
| Detke Michael J. Chief Medical Officer | 2021-07-07 | Sale | −6,942 | $56.27 | $390,626 | 523 | D: show line 9 in the form |
| Detke Michael J. Chief Medical Officer | 2021-07-07 | Sale | −523 | $56.99 | $29,806 | 0 | D: show line 10 in the form |
| Open-market sales · 58,261 sh · avg $54.04 · $3,148,172 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Detke Michael J. Chief Medical Officer | 2021-07-06 | Option exercise · Stock Option (right to buy) | −12,600 | 119,752 | D: show line 11 in the form | |||||
| Detke Michael J. Chief Medical Officer | 2021-07-07 | Option exercise · Stock Option (right to buy) | −17,400 | 102,352 | D: show line 12 in the form |
Loading xslF345X03/doc4.xml…